The emotional burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy: A qualitative study in Japan

被引:1
|
作者
LoPresti, Michael [1 ]
Igarashi, Ataru [2 ,3 ]
Sonohara, Yaoki [1 ]
Bowditch, Sally [4 ]
机构
[1] INTAGE Healthcare Inc, Value & Access Dept, Ochanomizu Sola City 13F,Kanda Surugadai 4-6,Chiyo, Tokyo 1010062, Japan
[2] Yokohama City Univ, Sch Med, Dept Publ Hlth, 22-2 Seto,Kanazawa ku, Yokohama, Kanagawa 2360027, Japan
[3] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Econ & Outcomes Res, 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan
[4] Jazz Pharmaceut UK Ltd, Dept Patient Access & Value, Spires House,5700 John Smith Dr,Oxford Business Pk, Oxford OX4 2RW, England
关键词
Epilepsy; Lennox-Gastaut syndrome; Dravet syndrome; Tuberous sclerosis complex; Caregiver burden; Qualitative; MANAGEMENT; CAREGIVERS; DIAGNOSIS; FAMILIES; IMPACT;
D O I
10.1016/j.yebeh.2024.109932
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Introduction: Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DS) are rare, childhood-onset conditions associated with severe, treatment-resistant epilepsy and developmental issues, including motor and cognitive impairment. Tuberous sclerosis complex (TSC) is a rare genetic disease commonly associated with epilepsy and other neuropsychiatric disorders. This cross-sectional, interview-based study examined the qualitative impact of caring for patients with LGS, DS, and TSC-associated epilepsy on caregivers in Japan, from the perspective of both caregivers and physicians. Methods: The survey included a pre-interview worksheet to describe caregivers' emotional journeys, followed by a <= 60-minute one-on-one interview. Eligible participants were Japanese caregivers of patients with LGS, DS, or TSC treated for epilepsy symptoms, and Japan-residing pediatricians or neurologists treating >= 3 patients with LGS, DS, and/or TSC. Interview question responses were subjected to content analysis to identify the most common response tendencies and themes. Results: Twenty-six caregivers responded (mean [standard deviation (SD)] age, 45.9 [9.5] years; age range 29-68; 92% female), caring for patients with LGS (n = 5), DS (n =10), and TSC (n = 11); patient mean (SD) age, 13.6 (10.0) years; age range 2-44; 27 % adults; 50 % female. Nineteen physicians, treating patients with LGS (n = 9), DS (n = 7), and TSC (n = 10), participated. Caregivers and physicians generally aligned on the factors affecting caregivers' emotional states / quality of life (QoL). The most frequently reported caregiver emotions at the time of diagnosis were shock and discouragement, anxiety for the future, and relief at receiving a diagnosis. Negative emotions throughout disease progression up until the time of survey were mainly caused by worsening of seizures, burden of constant caregiving / lack of free time, and patient's developmental issues. Positive emotions were linked to effective treatment / reduced seizures; more free time owing to the use of facilities, services, or other caregiving support; and developmental progress. Physicians acknowledged that caregivers required consultation services to support their emotional needs. In terms of unmet needs, caregiver and physician responses were aligned on the insufficient availability of services/facilities, the lack of effective treatments, and the uncertainties of adult patient care. Conclusions: Caregivers of patients with LGS, DS, or TSC-associated epilepsy in Japan reported a high degree of emotional burden related to frequent seizures, developmental issues, and constant caregiving. The burden of suboptimal treatment effectiveness, limited access to support services, and uncertainties in long-term care emphasize important unmet treatment needs.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Clinical presentation and evolution of Lennox-Gastaut syndrome in adult life: A study of patients attending an outpatient epilepsy clinic
    Giannakodimos, S.
    Kartsaklis, L.
    Kapsalakis, I. Z.
    Karageorgiou, C. E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 116 - 116
  • [32] AN OPEN-LABEL MULTICENTER STUDY OF TOPIRAMATE IN PATIENTS WITH THE LENNOX-GASTAUT SYNDROME
    FRENCH, JA
    BOURGEOIS, BFD
    DREIFUS, FE
    GLAUSER, TA
    RITTER, RJ
    REIFE, RA
    SHEILDS, WD
    CONOVER, D
    NEUROLOGY, 1995, 45 (04) : A250 - A250
  • [33] A comprehensive systematic literature review of the burden of illness of Lennox-Gastaut syndrome on patients, caregivers, and society
    Cross, J. Helen
    Benitez, Arturo
    Roth, Jeannine
    Andrews, J. Scott
    Shah, Drishti
    Butcher, Emma
    Jones, Aimee
    Sullivan, Joseph
    EPILEPSIA, 2024, 65 (05) : 1224 - 1239
  • [34] Lennox-Gastaut syndrome of unknown cause: Phenotypic characteristics of patients in the Epilepsy Phenome/Genome Project
    Widdess-Walsh, Peter
    Dlugos, Dennis
    Fahlstrom, Robyn
    Joshi, Sucheta
    Shellhaas, Renee
    Boro, Alex
    Sullivan, Joseph
    Geller, Eric
    Abou-Khalil, Bassel
    Alldredge, Brain
    Bautista, Jocelyn
    Berkovic, Sam
    Bluvstein, Judith
    Cascino, Gregory
    Consalvo, Damian
    Cristofaro, Sabrina
    Crumrine, Patricia
    Devinsky, Orrin
    Epstein, Michael
    Fiol, Miguel
    Fountain, Nathan
    Fox, Kristen
    French, Jacqueline
    Karn, Catharine Freyer
    Friedman, Daniel
    Glauser, Tracy
    Glynn, Simon
    Haas, Kevin
    Haut, Sheryl
    Hayward, Jean
    Helmers, Sandra
    Kanner, Andres
    Kirsch, Heidi
    Knowlton, Robert
    Kossoff, Eric
    Kuperman, Rachel
    Kuzniecky, Ruben
    Lowenstein, Daniel
    McGuire, Shannon
    Motika, Paul
    Nesbitt, Gerard
    Novotny, Edward
    Ottman, Ruth
    Paolicchi, Juliann
    Parent, Jack
    Park, Kristen
    Poduri, Annapurna
    Risch, Neil
    Sadleir, Lynette
    Scheffer, Ingrid
    EPILEPSIA, 2013, 54 (11) : 1898 - 1904
  • [35] Magnetoencephalographic studies of focal epileptic activity in three patients with epilepsy suggestive of Lennox-Gastaut syndrome
    Sakurai, Kotaro
    Tanaka, Naoaki
    Kamada, Kyousuke
    Takeuchi, Fumiya
    Takeda, Youji
    Koyama, Tsukasa
    EPILEPTIC DISORDERS, 2007, 9 (02) : 158 - 163
  • [36] COST-EFFECTIVENESS OF CANNABIDIOL (CBD) FOR THE TREATMENT OF SEIZURES IN PATIENTS WITH TREATMENT-RESISTANT LENNOX-GASTAUT SYNDROME OR DRAVET SYNDROME IN THE NETHERLANDS
    Siddiqui, J.
    Bowditch, S.
    VALUE IN HEALTH, 2023, 26 (12) : S127 - S128
  • [37] Efficacy and safety of perampanel in patients with seizures associated with Lennox-Gastaut syndrome: A randomized trial
    Vossler, David G.
    Porter, Brenda E.
    Kira, Ryutaro
    Lee, Jeehun
    Aeby, Alec
    Patten, Anna
    Cheng, Jocelyn Y.
    Ngo, Leock Y.
    EPILEPSIA, 2024,
  • [38] Efficacy of soticlestat treatment by seizure type in patients with Dravet syndrome or Lennox-Gastaut syndrome in a phase 2, randomized, placebo-controlled study (ELEKTRA)
    Murthy, V.
    Dlugos, D.
    Khan, Y.
    Hsiao, S.
    Benitez, A.
    Asgharnejad, M.
    EPILEPSIA, 2023, 64 : 153 - 154
  • [39] Efficacy of Soticlestat Treatment by Seizure Type in Patients with Dravet Syndrome or Lennox-Gastaut Syndrome in a Phase 2, Randomized, Placebo-controlled Study (ELEKTRA)
    Murthy, Venkatesha
    Dlugos, Dennis
    Khan, Yasir
    Hsiao, Samuel
    Benitez, Arturo
    Asgharnejad, Mahnaz
    NEUROLOGY, 2023, 100 (17)
  • [40] Diarrhoea in patients with Lennox-Gastaut Syndrome (LGS) or Dravet Syndrome (DS) enrolled in four phase 3 Clinical Trials of Cannabidiol (CBD)
    Nabbout, Rima
    Bhathal, Hari
    Zolnowska, Marta
    Sidhu, Meneka
    Li, Jie
    Hyland, Kerry
    Nortvedt, Charlotte
    EPILEPSIA, 2021, 62 : 273 - 274